metricas
covid
Medicina Clínica (English Edition) Remdesivir plus dexamethasone is associated to improve in the clinical outcome o...
Journal Information

Statistics

Follow this link to access the full text of the article

Original article
Remdesivir plus dexamethasone is associated to improve in the clinical outcome of COVID-19 hospitalized patients regardless of their vaccination status
Remdesivir más dexametasona se asocian a una reducción de los eventos clínicos en los pacientes hospitalizados por COVID-19, independientemente de su estado de vacunación
Enrique Bernala,
Corresponding author
ebm.hgurs@gmail.com

Corresponding author.
, Eva García-Villalbab, Eduardo Ponsa, Maria Dolores Hernándeza, Carlos Báguenaa, Gabriel Puchea, Paula Cartera, Mónica Martineza, Antonia Alcaraza, Cristina Tomása, Angeles Muñoza, Maria Rosario Vicentec, Maria Luz Nuñezc, Natalia Sanchoe, Mari Carmen Villalbaa, Alfredo Canoa, Alfredo Minguelad
a Infectious Disease Unit, Reina Sofia University Hospital and Biomedical Research Institute of Murcia (IMIB), Murcia, Spain
b Internal Medicine Service, Los Arcos del Mar Menor Hospital and Biomedical Research Institute of Murcia (IMIB), Murcia, Spain
c Microbiology Service, Reina Sofia University Hospital and Biomedical Research Institute of Murcia (IMIB), Murcia, Spain
d Immunology Service, Virgen de la Arrrixaca University Clinical Hospital (HCUVA), Biomedical Research Institute of Murcia (IMIB), Murcia, Spain
e Laboratory Medicine Department, Reina Sofia University Hospital and Biomedical Research Institute of Murcia (IMIB), Murcia, Spain
Read
282
Times
was read the article
3
Total PDF
279
Total HTML
Share statistics
Article information
ISSN: 23870206
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 10 7 0 7
2025 9 10 0 10
2025 8 9 0 9
2025 7 18 0 18
2025 6 10 0 10
2025 5 12 0 12
2025 4 25 0 25
2025 3 18 0 18
2025 2 16 0 16
2025 1 13 2 15
2024 12 9 0 9
2024 11 5 0 5
2024 10 18 0 18
2024 9 14 0 14
2024 8 21 1 22
2024 7 11 0 11
2024 6 8 0 8
2024 5 8 0 8
2024 4 4 0 4
2024 3 17 0 17
2024 2 13 0 13
2024 1 12 0 12
2023 12 1 0 1
Show all

Follow this link to access the full text of the article